Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Béhé M, Becker W, Gotthardt M, Angerstein C, Behr TM. Béhé M, et al. Among authors: becker w. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1140-6. doi: 10.1007/s00259-003-1178-1. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768330 Clinical Trial.
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W. Behr TM, et al. Among authors: becker w. Int J Cancer. 1998 May 29;76(5):738-48. doi: 10.1002/(sici)1097-0215(19980529)76:5<738::aid-ijc20>3.0.co;2-z. Int J Cancer. 1998. PMID: 9610734 Free article.
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W. Behr TM, et al. Among authors: becker w. Cancer Res. 1999 Jun 1;59(11):2635-43. Cancer Res. 1999. PMID: 10363986
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD, Apostolidis C, Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W. Behr TM, et al. Among authors: becker w. Clin Cancer Res. 1999 Oct;5(10 Suppl):3031s-3043s. Clin Cancer Res. 1999. PMID: 10541340
2,054 results